Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest Cholesterol Stories

Statins Negatively Interact With Other Meds
2013-11-25 16:05:06

Brett Smith for redOrbit.com - Your Universe Online A new study from a team of American researchers published in the Journal of Clinical Lipidology has found undesirable drug interactions with statins are causing many to discontinue using the cholesterol-lowering drugs. Many drugs are known to add to a common side effect of taking statins – muscle pain. The pain often pushes patients to discontinue using the lifesaving, cholesterol-lowering drugs. While these undesirable...

2013-11-24 23:00:17

Crunch Cholesterol designed by Colin Carmichael is a new book that covers detailed instructions on how to reduce high cholesterol levels effortlessly. A detailed Crunch Cholesterol overview on the site Vkoolelite indicates if this book is worth buying. Seattle, Wa (PRWEB) November 24, 2013 Cholesterol is a type of fat (lipid) in their blood. If people have too much cholesterol, it starts to build up in their arteries (blood vessels). The buildup of cholesterol narrows their arteries and...

2013-11-21 13:53:03

Obesity and diabetes have become a global epidemic leading to severe cardiovascular disease. Researchers at the University of Utah believe their recent identification of brown fat stem cells in adult humans may lead to new treatments for heart and endocrine disorders, according to a new study published in the peer-reviewed journal Stem Cells. The study was led by Amit N. Patel, M.D. M.S., director of Clinical Regenerative Medicine and Tissue Engineering, and associate professor in the...

2013-11-20 12:27:41

Multiple presentations of study results at the American Heart Association 2013 Scientific Sessions DALLAS, Nov. 20, 2013 /PRNewswire/ -- Results of a Phase 2a trial of CSL112, sponsored by CSL Limited, demonstrated favorable safety and tolerability when administered to patients with stable atherothrombotic disease. The trial data for CSL112 also showed a dramatic and rapid increase in key biomarkers of reverse cholesterol transport, a process by which cholesterol is removed from...

2013-11-19 20:21:30

Data Presented at American Heart Association Scientific Sessions 2013 and Simultaneously Published in Circulation THOUSAND OAKS, Calif., Nov. 19, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from the Open Label Study of Long TERm Evaluation Against LDL-C (OSLER) trial, a long-term controlled 52-week safety and efficacy study, that showed monthly treatment with evolocumab (AMG 145), an investigational fully human monoclonal antibody that inhibits PCSK9, a protein that...

AHA Controversy Statins Recommendations
2013-11-19 14:50:13

Brett Smith for redOrbit.com - Your Universe Online Last week, the American Heart Association (AHA) and the American College of Cardiology (ACC) made significant waves when they released a set of recommendations for healthcare providers that suggested 33 million more Americans could benefit from cholesterol-lowering drugs called statins. This week, those recommendations are being called into question as a pair of Harvard Medical School professors published a report in the journal The...

2013-11-18 20:44:39

Seth S. Martin, M.D., of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, and colleagues developed a method for estimating low-density lipoprotein cholesterol (LDL-C) levels that is more accurate than the standard measure. Low-density lipoprotein cholesterol is the primary target for treatment in national and international clinical practice guidelines. Conventionally, LDL-C is estimated by the Friedewald equation, which estimates LDL-C as (total...

2013-11-18 20:38:54

Findings follow previous study showing that commonly used equation underestimates heart disease danger for many at high risk Johns Hopkins researchers have developed a more accurate way to calculate low-density lipoprotein (LDL) cholesterol, the so-called "bad" form of blood fat that can lead to hardening of the arteries and increase the risk of heart attack and stroke. If confirmed and adopted by medical laboratories that routinely calculate blood cholesterol for patients, the researchers...

2013-11-18 20:21:13

- Data presented today at the American Heart Association CARLSBAD, Calif., Nov. 18, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced new results from its Phase 2 study of ISIS-APOCIII(Rx) as a monotherapy in patients with very high to severely high triglycerides. These new data and an overall summary of the Phase 2 program for ISIS-APOCIII(Rx) were presented today by Dr. Rosanne Crooke at the American Heart Association Scientific Sessions in Dallas. In...

2013-11-18 12:29:41

RALEIGH, N.C., Nov. 18, 2013 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced that low-density lipoprotein particle (LDL-P) number can predict cardiovascular events independently of LDL cholesterol (LDL-C) concentrations in a real-world environment, as presented in a poster session at...